Kátia L.P. Morais

A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production

Durvanei Augusto Maria, Jean Gabriel de Souza, Kátia L.P. Morais et al. · Investigational New Drugs · 2012 · 43 citations · Full text

Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of Neural Stem Cells

Claudiana Lameu, Cleber A. Trujillo, Telma T. Schwindt et al. · Journal of Biological Chemistry · 2012 · 38 citations · Full text

Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B2 and M1 muscarinic acetylcholine receptors

Kátia L.P. Morais, Mirian A.F. Hayashi, Fernanda Miriane Bruni et al. · Biochemical Pharmacology · 2010 · 38 citations · Full text

Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action

Kátia L.P. Morais, Danielle Ianzer, José Rodolfo R. Miranda et al. · Peptides · 2013 · 36 citations

Hypertension, Biochemistry, Medicine +5

A Genome-wide Association Study Identifies <i>SERPINB10, CRLF3, STX7</i>, <i>LAMP3, IFNG-AS1</i>, and <i>KRT80</i> As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil

Léa Cristina Castellucci, Lucas Almeida, Svetlana Cherlin et al. · Clinical Infectious Diseases · 2020 · 27 citations · Full text